Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic (CROSBI ID 110999)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Cabrera-Abreu, J.C. ; Davies, P. ; Matek, Zrinjka ; Murphy, M.S. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic // Archives of disease in childhood, 89 (2004), 1; 69-71

Podaci o odgovornosti

Cabrera-Abreu, J.C. ; Davies, P. ; Matek, Zrinjka ; Murphy, M.S.

engleski

Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic

To determine the reliability of a panel of blood tests in screening for ulcerative colitis and Crohn's disease. The subjects were 153 children referred to a paediatric gastroenterology department with possible inflammatory bowel disease (IBD). Of these, 103 were found to have IBD (Crohn's disease 60, ulcerative colitis 37, indeterminate colitis 6). The 50 without IBD formed the controls. Blood tests evaluated included haemoglobin, platelet count, ESR, CRP, and albumin. Receiver operating characteristic curves were used where possible to determine optimal threshold values. Binary logistic regression analysis was used to investigate the five screening tests in combination, and a stepwise method was used to find the best test combination. The optimal screening strategy used a combination of haemoglobin and platelet count and "1 of 2 abnormal" as the criterion for positivity. This was associated with a sensitivity of 90.8% (95% CI 83.3 to 95.7%), a specificity of 80.0% (95% CI 65.7 to 89.8%), and positive and negative predictive values of 94.4% and 75.9% respectively. Haemoglobin and platelet count provide a useful screening test combination for patients with suspected IBD. These tests are not completely reliable however. If clinical suspicion is high further investigations are required.

screening; inflammatory bowel disease

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

89 (1)

2004.

69-71

objavljeno

0003-9888

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost